Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA structure/function "implied" claims proposed ban would alter statute -- NHA.

This article was originally published in The Tan Sheet

Executive Summary

STRUCTURE/FUNCTION "IMPLIED" CLAIMS PROPOSED BAN ALTERS STATUTE, the Nutritional Health Alliance says in July 8 comments on FDA's April 29 proposed rule regarding structure/function claims ("The Tan Sheet" May 4, pp. 1-7). By proposing that labeled "reference to a characteristic set of signs or symptoms, even in the absence of the name of the disease, can be understood as a reference to the disease itself," NHA says "the agency is attempting to legislate by ignoring the language" of the Dietary Supplement Health & Education Act and "creating a whole new set of rules which alter and restrict the statutory mandate."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088668

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel